文献速递临床试验与 GCP医学教育与科研方法

为痴呆老年女性照护者提供乳腺癌筛查决策支持:随机对照试验研究方案

Supporting breast cancer screening decisions for caregivers of older women with dementia: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2018-12-12

DECAD试验为随机对照试验,计划纳入426对≥75岁ADRD女性及其家庭照护者,随机接受决策辅助或居家安全主动对照信息,主要结局为照护者决策冲突,次要结局为决策自我效能,并随访至24个月通过电子病历评估乳腺钼靶使用及负担。

要点

  • 决策辅助针对ADRD对预期寿命和乳腺钼靶获益的影响。
  • 主要结局为照护者决策冲突,次要结局为决策自我效能。
  • 假设决策辅助可降低决策冲突、提高自我效能并减少钼靶使用。

核心结论

  • 研究假设接受决策辅助的照护者决策冲突更低、决策自我效能更高,且决策辅助可减少ADRD老年女性的乳腺钼靶使用。

研究设计与样本

  • DECAD试验为随机对照临床试验,计划从印第安纳州诊所和初级保健机构纳入426对≥75岁ADRD女性及其家庭照护者。
  • 受试对随机接受新型循证决策辅助或关于居家安全的主动对照信息。

主要发现

  • 原文未报告研究结果,仅报告研究设计与假设。

关键数值与推荐

  • 主要结局为照护者决策冲突,次要结局为照护者决策自我效能。
  • 15个月随访包括照护者半结构化访谈及电子病历审查乳腺钼靶讨论、医嘱、完成、结果和负担。
  • 24个月随访提取电子病历中乳腺钼靶医嘱、实施、结果和负担数据。

临床怎么用

  • 决策辅助包含ADRD对预期寿命的影响、乳腺钼靶的获益及对ADRD老年女性生活质量的影响等信息。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Alzheimer's disease and related dementias (ADRD) impact a woman's life expectancy and her ability to participate in medical decision-making about breast cancer screening, necessitating the involvement of family caregivers. Making decisions about mammography screening for women with ADRD is stressful. There are no data that suggest that breast cancer screening helps women with ADRD live longer or better. Decision aids may improve the quality of decision-making about mammography for ADRD patients and may inform family caregivers about the risks, benefits, and need for decision-making around mammography screening. METHODS/DESIGN: The Decisions about Cancer Screening in Alzheimer's Disease (DECAD) trial, a randomized controlled clinical trial, will enroll 426 dyads of older women with ADRD (≥75 years) and a family caregiver from clinics and primary-care practices in Indiana to test a novel, evidence-based decision aid. This decision aid includes information about the impact of ADRD on life expectancy, the benefit of mammograms, and the impact on the quality of life for older women with ADRD. Dyads will be randomized to receive the decision aid or active control information about home safety. This trial will examine the effect on the caregiver's decisional conflict (primary outcome) and the caregiver's decision-making self-efficacy (secondary outcome). A second follow-up at 15 months will include a brief, semi-structured interview with the caregiver regarding the patient's experience with mammograms and decision-making about mammograms. At the same time, a review of the patient's electronic medical record (EMR) will look at discussions about mammography with their primary-care physician and mammogram orders, receipt, results, and burden (e.g., additional diagnostic procedures due to false-positive results, identification of an abnormality on the screening exam but further work-up declined, and identification of a clinically unimportant cancer). A third follow-up at 24 months will extract EMR data on mammogram orders, occurrences, results, and the burden of mammograms. DISCUSSION: We hypothesize that caregivers who receive the decision aid will have lower levels of decisional conflict and higher levels of decision-making self-efficacy compared to the control group. We also hypothesize that the DECAD decision aid will reduce mammography use among older women with ADRD. TRIAL REGISTRATION: Clinical Trials Register, NCT03282097 . Registered on 13 September 2017.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Fowler NR, Schonberg MA, Sachs GA, et al. Supporting breast cancer screening decisions for caregivers of older women with dementia: study protocol for a randomized controlled trial. Trials. 2018. PMID: 30541634. doi:10.1186/s13063-018-3039-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。